Literature DB >> 3842319

Phenotypic and genotypic analysis of Hodgkin's disease derived cell lines: histopathological and clinical implications.

V Diehl, M Pfreundschuh, C Fonatsch, H Stein, M Falk, H Burrichter, M Schaadt.   

Abstract

Five Hodgkin's disease (HD) derived cell lines were established in vitro in our laboratory in the last seven years. Morphological, cytochemical, immunological and cytogenetic marker analysis demonstrated that the in vitro cells represent genotypically and phenotypically the in vivo Hodgkin (H) and Sternberg-Reed (SR) cells in biopsy specimens. The cultured cells resemble haematolymphoid cells at different stages of maturation. Four of the five continue to grow in vitro as suspension cells after more than 50 months. Four more in vitro HD-derived lines were described recently by several authors. A summary of the various marker characteristics of these in vitro lines is given as a synopsis of the phenotypic marker spectrum and is discussed in comparison with our own cell lines. There is a striking similarity between two of the newly established lines (CO, HDLM-2) and our lines whereas the two other in vitro established cultures seem to resemble cell species further along the line of maturation to B lymphocytes (DEV) and monocytes (SU-HD-1). Gene rearrangement experiments undertaken with the L428, L540, L591 and the CO cell line show that the L428 and 591 cells have undergone gene rearrangement, the L428 being compatible with the genotypic state of a pre-B cell; the L591 cells, similarly rearranged furthermore demonstrated functional light chain rearrangement, compatible with B-cell development. By cytogenetic analysis chromosome 7 was found to be affected in all our described lines. This chromosome appears to be particularly unstable and vulnerable in patients with HD, since all tested cell lines revealed multiple abnormalities of this chromosome, a finding which is in accordance with observations made by other investigators in HD-biopsy cells. Since similar structural changes or loss of chromosome 7 is a characteristic event in cases of secondary acute non-lymphocytic leukaemia, it is speculated that this form of secondary neoplasia could resemble the blast crisis, as observed in chronic myeloid leukaemia.

Entities:  

Mesh:

Year:  1985        PMID: 3842319

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  10 in total

Review 1.  Genetic markers on chromosome 7.

Authors:  L C Tsui
Journal:  J Med Genet       Date:  1988-05       Impact factor: 6.318

2.  Expression of the matrix metalloproteinase 9 in Hodgkin's disease is independent of EBV status.

Authors:  J R Flavell; K R Baumforth; D M Williams; M Lukesova; J Madarova; V Noskova; J Prochazkova; D Lowe; Z Kolar; P G Murray; P N Nelson
Journal:  Mol Pathol       Date:  2000-06

3.  Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.

Authors:  R C Bargou; F Emmerich; D Krappmann; K Bommert; M Y Mapara; W Arnold; H D Royer; E Grinstein; A Greiner; C Scheidereit; B Dörken
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

4.  Quantity of nuclear DNA in malignancies and benign lymphadenopathies associated with Epstein-Barr virus.

Authors:  T Lehtinen; M Lehtinen; R Aine; K Dammert; P Kulomaa; M Alavaikko; P Leinikki
Journal:  J Clin Pathol       Date:  1989-07       Impact factor: 3.411

5.  Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile.

Authors:  Johan H Gibcus; Lu Ping Tan; Geert Harms; Rikst Nynke Schakel; Debora de Jong; Tjasso Blokzijl; Peter Möller; Sibrand Poppema; Bart-Jan Kroesen; Anke van den Berg
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

6.  Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines.

Authors:  Danny F Dukers; Joost C van Galen; Cindy Giroth; Patty Jansen; Richard G A B Sewalt; Arie P Otte; Hanneke C Kluin-Nelemans; Chris J L M Meijer; Frank M Raaphorst
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

7.  Cellular localization and processing of primary transcripts of exonic microRNAs.

Authors:  Izabella Slezak-Prochazka; Joost Kluiver; Debora de Jong; Gertrud Kortman; Nancy Halsema; Sibrand Poppema; Bart-Jan Kroesen; Anke van den Berg
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

8.  New insights into the phenotype of human dendritic cell populations.

Authors:  Georgina Jane Clark; Fiona Kupresanin; Phillip Dieter Fromm; Xinsheng Ju; Leticia Muusers; Pablo Alejandro Silveira; Zehra Elgundi; Robin Edward Gasiorowski; Michael Stefan Papadimitrious; Christian Bryant; Kenneth Maan Liong Lee; Candice Jane Clarke; James William Young; Andrew Chan; Andrew Harman; Rachel Botting; Raquel Cabezón; Daniel Benitez-Ribas; Anna Elizabeth Stella Brooks; Phillip Rodney Dunbar; Derek Nigel John Hart
Journal:  Clin Transl Immunology       Date:  2016-01-29

9.  Characterization of a novel Hodgkin cell line, HD-MyZ, with myelomonocytic features mimicking Hodgkin's disease in severe combined immunodeficient mice.

Authors:  R C Bargou; M Y Mapara; C Zugck; P T Daniel; M Pawlita; H Döhner; B Dörken
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

10.  Independent Mechanisms Lead to Genomic Instability in Hodgkin Lymphoma: Microsatellite or Chromosomal Instability .

Authors:  Corina Cuceu; Bruno Colicchio; Eric Jeandidier; Steffen Junker; François Plassa; Grace Shim; Justyna Mika; Monika Frenzel; Mustafa Al Jawhari; William M Hempel; Grainne O'Brien; Aude Lenain; Luc Morat; Theodore Girinsky; Alain Dieterlen; Joanna Polanska; Christophe Badie; Patrice Carde; Radhia M'Kacher
Journal:  Cancers (Basel)       Date:  2018-07-13       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.